Hua Wu, Shan-Mei Wang, Gong-Zheng Hu, Yu-Shan Pan, Bao-Guang Liu and Zhi-Pei He
Page: 3870-3875 | Received 21 Sep 2022, Published online: 21 Sep 2022
Full Text Reference XML File PDF File
Thirty two Escherichia coli isolates recovered from diseased ducks diagnosed with colibacillosis in China between 2010 and 2011 were characterized for detection of Extended-Spectrum β-Lactamases (ESBLs) by phenotypic screening and confirmatory test provided by the Clinical Laboratory Standards Institute and antimicrobial susceptibility profiles via agar disk diffusion and a broth doubling dilution method. Results showed 7 of the 32 E. coli isolates analyzed (21.87%) were found to be ESBL producers. The resistant rates of ESBL producers were >28.6% against third generation cephalosporins and semisynthetic penicillins and as high as 100% against amoxicillin, ampicillin and ceftiofur. All 32 isolates were sensitive to imipenem, meropenem and cefepime and the susceptible rates of all 32 isolates to β-lactam antibiotics in combination with enzyme inhibitors were higher than those of β-lactam antibiotics alone. Therefore, ESBL-producing isolates had multi-drug resistance and enzyme inhibitors can partially solve the drug resistance problem.
Hua Wu, Shan-Mei Wang, Gong-Zheng Hu, Yu-Shan Pan, Bao-Guang Liu and Zhi-Pei He. Phenotypic Detection and Drug Resistance Analysis of Extended-Spectrum β-Lactamases among Escherichia coli Isolates from Diseased Duck.
DOI: https://doi.org/10.36478/javaa.2012.3870.3875
URL: https://www.makhillpublications.co/view-article/1680-5593/javaa.2012.3870.3875